Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -21.3% | +138.9% | 1 / 3 | -24.3% | +11.67 pp | +3.68 pp | +24.5% | 0.43 | 4.72 | 74,2 | −24,3% | 10,8 | +1,3% | 4.72 | 23.32 | −79,8% |
| Pts | 0 | 12 | 4 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 15.000 (close price on 2026-10-19)EPS (TTM): 3.178
Financial charts
1.Revenue & growth
VND bn74,2Q2/26
1.Revenue & growth
VND bn74,2Q2/26
2.Profit & growth
VND bn10,8Q2/26
3.Profit mix (Penman)
VND bn97,1Q2/26
4.Margins & cost structure
%28.8%Q2/26
5.Returns & cash cycle
% · days19.4%Q2/26
6.Earnings quality & cash
VND bn-91,0Q2/26
7.Asset structure
VND bn588Q2/26
8.Funding & debt health
VND bn · times588Q2/26
9.Revenue backlog
VND bn18,8Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %461Q2/26
Adjusted EPS growth, latest quarter
1.3%
Average adjusted EPS growth, 3 quarters
146%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26